Seoul, South Korea

Gyu-bon Cho


Average Co-Inventor Count = 6.0

ph-index = 1


Company Filing History:


Years Active: 2023-2024

Loading Chart...
2 patents (USPTO):Explore Patents

Title: Gyu-bon Cho: Innovator in Genome Manipulation

Introduction

Gyu-bon Cho is a prominent inventor based in Seoul, South Korea. He has made significant contributions to the field of genetic engineering, particularly in the area of gene expression regulation. With a total of two patents to his name, Cho is recognized for his innovative approaches to addressing genetic challenges.

Latest Patents

Gyu-bon Cho's latest patents focus on artificial genome manipulation for gene expression regulation. The first patent relates to an expression control composition designed to manage the expression of duplicate genes. This invention also includes a method for treating or improving diseases caused by gene duplication using the aforementioned expression control composition. The implications of this work are profound, as it offers potential solutions for various genetic disorders.

Career Highlights

Cho is currently associated with Toolgen Inc., a company that specializes in gene editing technologies. His work at Toolgen has positioned him at the forefront of genetic research and innovation. His contributions have not only advanced scientific understanding but also opened new avenues for therapeutic applications.

Collaborations

Gyu-bon Cho has collaborated with notable colleagues in his field, including Seokjoong Kim and Dong Woo Song. These partnerships have fostered a collaborative environment that enhances research outcomes and drives innovation.

Conclusion

Gyu-bon Cho's work in artificial genome manipulation exemplifies the potential of innovative research in genetics. His patents and collaborations reflect a commitment to advancing the field and improving health outcomes through scientific discovery.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…